FDA letters target missing clinical trial reporting The FDA is pressing drugmakers and other trial sponsors to report clinical trial results that they are required to submit. The agency sent reminder letters to more than 2,200 companies and researchers, emphasizing that they have obligations to…
Continue reading...
Continue reading...